The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy. Pfizer Inc, Metsera, Obesity, Drugs (Pharmaceuticals), Novo Nordisk A/S, Mergers, Acquisitions and Divestitures, GLP-1 RAs (Drug), Start-ups, Ozempic (Drug), Weight, United States, Denmark, Eli Lilly and Company Read More
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
